BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Geer MA, Bakker CT, Koizumi N, Mizuguchi H, Wesseling JG, Oude Elferink RP, Bosma PJ. Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivoWorld J Gastroenterol 2009; 15(22): 2754-2762 [PMID: 19522026 DOI: 10.3748/wjg.15.2754] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer. 2010;10:165-180. [PMID: 20179713 DOI: 10.1038/nrc2806] [Cited by in Crossref: 763] [Cited by in F6Publishing: 724] [Article Influence: 63.6] [Reference Citation Analysis]
2 Behr M, Kaufmann JK, Ketzer P, Engelhardt S, Mück-Häusl M, Okun PM, Petersen G, Neipel F, Hassel JC, Ehrhardt A, Enk AH, Nettelbeck DM. Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds. PLoS One 2014;9:e95723. [PMID: 24760010 DOI: 10.1371/journal.pone.0095723] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
3 Zozulya SA, Udovichenko IP. [Eph family receptors as therapeutic targets]. Bioorg Khim 2012;38:267-79. [PMID: 22997698 DOI: 10.1134/s106816201203017x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Toth K, Dhar D, Wold WS. Oncolytic (replication-competent) adenoviruses as anticancer agents. Expert Opin Biol Ther 2010;10:353-68. [PMID: 20132057 DOI: 10.1517/14712590903559822] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
5 Liu R, Li X, Xiao W, Lam KS. Tumor-targeting peptides from combinatorial libraries. Adv Drug Deliv Rev 2017;110-111:13-37. [PMID: 27210583 DOI: 10.1016/j.addr.2016.05.009] [Cited by in Crossref: 95] [Cited by in F6Publishing: 82] [Article Influence: 19.0] [Reference Citation Analysis]
6 Puig-saus C, Rojas LA, Laborda E, Figueras A, Alba R, Fillat C, Alemany R. iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy. Gene Ther 2014;21:767-74. [DOI: 10.1038/gt.2014.52] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
7 Mitra S, Duggineni S, Koolpe M, Zhu X, Huang Z, Pasquale EB. Structure-activity relationship analysis of peptides targeting the EphA2 receptor. Biochemistry. 2010;49:6687-6695. [PMID: 20677833 DOI: 10.1021/bi1006223] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
8 Pan Y, Du X, Zhao F, Xu B. Magnetic nanoparticles for the manipulation of proteins and cells. Chem Soc Rev 2012;41:2912-42. [PMID: 22318454 DOI: 10.1039/c2cs15315g] [Cited by in Crossref: 284] [Cited by in F6Publishing: 250] [Article Influence: 28.4] [Reference Citation Analysis]
9 Gray BP, Brown KC. Combinatorial peptide libraries: mining for cell-binding peptides. Chem Rev 2014;114:1020-81. [PMID: 24299061 DOI: 10.1021/cr400166n] [Cited by in Crossref: 143] [Cited by in F6Publishing: 126] [Article Influence: 15.9] [Reference Citation Analysis]
10 Coughlan L, Alba R, Parker AL, Bradshaw AC, McNeish IA, Nicklin SA, Baker AH. Tropism-modification strategies for targeted gene delivery using adenoviral vectors. Viruses. 2010;2:2290-2355. [PMID: 21994621 DOI: 10.3390/v2102290] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 7.1] [Reference Citation Analysis]
11 Posthumadeboer J, Piersma SR, Pham TV, van Egmond PW, Knol JC, Cleton-Jansen AM, van Geer MA, van Beusechem VW, Kaspers GJ, van Royen BJ, Jiménez CR, Helder MN. Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery. Br J Cancer 2013;109:2142-54. [PMID: 24064975 DOI: 10.1038/bjc.2013.578] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
12 Toth K, Wold WS. Increasing the efficacy of oncolytic adenovirus vectors. Viruses 2010;2:1844-66. [PMID: 21994711 DOI: 10.3390/v2091844] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
13 Riedl SJ, Pasquale EB. Targeting the Eph System with Peptides and Peptide Conjugates. Curr Drug Targets 2015;16:1031-47. [PMID: 26212263 DOI: 10.2174/1389450116666150727115934] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]